Had the now-scrapped changes to FoI laws been in place in recent years, it is likely that the previously unlawful arrangements for the Opiate Dependence Treatment Program and the employment workaround that led a health department official to secretly release confidential company pricing information, leading to its publication in the infamous 'Vancouver' poster, would never have been exposed.
Labor’s FoI backdown is a welcome victory for transparency and accountability
March 10, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Australian dementia experts push back on Cochrane Review, defending new treatments
April 20, 2026 - - Latest News -
Australia’s drug pricing dogma risks failing patients in the face of international realities
April 20, 2026 - - Latest News -
Free RSV vaccines roll out to protect senior Australians ahead of winter
April 20, 2026 - - Latest News -
Alterity strengthens board with seasoned biotech leader as it advances flagship therapy
April 19, 2026 - -
Immuron posts steady global gains as Travelan drives third quarter sales growth
April 19, 2026 - - Australian Biotech -
The 'Dispatched' Week in Review Podcast - 17 April
April 17, 2026 - - Podcast -
Mark Butler confirms new and expanded cancer medicine listings
April 17, 2026 - - Latest News
